Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 162
- Registration Number
- NCT00370747
A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia
Not Applicable
Completed
- Conditions
- MyopiaAstigmatism
- Interventions
- Device: The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithmDevice: The Bausch & Lomb Zyoptix Tissue Saving algorithm
- First Posted Date
- 2006-08-17
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 127
- Registration Number
- NCT00365677
A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.
Phase 3
Completed
- Conditions
- Acute Bacterial Conjunctivitis
- Interventions
- Drug: VehicleDrug: ISV-403
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 957
- Registration Number
- NCT00347932
A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: Next Generation Diagnostic Instrument (NGDI)Device: Zyoptix Diagnostic Workstation (ZDW)
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 76
- Registration Number
- NCT00347594
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 4
- Registration Number
- NCT00347646
- Locations
- 🇺🇸
University Hospitals of Cleveland, Cleveland, Ohio, United States
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 29
- Registration Number
- NCT00348439
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik
Not Applicable
Withdrawn
- Conditions
- MyopiaAstigmatism
- Interventions
- Device: 217z Laser
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Registration Number
- NCT00347997
A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis
Phase 3
Completed
- Conditions
- Acute Bacterial Conjunctivitis
- Interventions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 1161
- Registration Number
- NCT00348348
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
Not Applicable
Completed
- Conditions
- HyperopiaAstigmatism
- Interventions
- Device: Technolas 217z Zyoptix Laser
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 80
- Registration Number
- NCT00348205
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Phase 3
Completed
- Conditions
- PainInflammation
- Interventions
- Drug: bromfenac ophthalmic solutionDrug: placebo comparator
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 522
- Registration Number
- NCT00333918
© Copyright 2025. All Rights Reserved by MedPath